Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3

The Journal of Obstetrics and Gynaecology Research
Kazu UedaTadao Tanaka

Abstract

CD147 is a membrane glycoprotein that is expressed in various cancer cells and is involved in tumor invasion and metastasis by inducing stromal fibroblastic cells to produce matrix metalloproteinases. This study was carried out to evaluate the correlation between CD147 expression and various clinicopathologic parameters, including histological grade and prognosis in a small sample set of human ovarian cancer patients. Paraffin-embedded surgical tissue samples from 25 patients with ovarian serous and endometrioid adenocarcinoma were stained with anti-CD147 antibody (monoclonal antibody 12C3: MoAb 12C3) for immunohistochemical analysis. CD147 protein was expressed in 84.0% (21 of 25 cases) of cancerous lesions, but not in normal lesions. CD147 expression by ovarian cancer cells was inversely correlated with overall survival. There was no correlation between CD147 expression and histological grade. These results suggest that measurement of CD147 expression may enhance the understanding of the pathophysiology of epithelial ovarian cancer.

References

Jun 1, 1996·Journal of Surgical Oncology·G P YazdiL J Humphrey
Oct 7, 1998·International Journal of Cancer. Journal International Du Cancer·N TsumuraS Fujimoto
Jan 19, 1999·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·W H WenM F Press
Jan 19, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·S G Silverberg
Dec 8, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·D Mayr, J Diebold
Jul 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J. BruggheC. Fisher
Nov 26, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R A M SagarraS F M Derchain
Sep 4, 2003·Journal of the National Cancer Institute·Andreas du BoisUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group
Dec 17, 2003·Gynecologic Oncology·Cynthia D O'MalleyGary S Leiserowitz
Feb 7, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A P HeintzS Pecorelli
Apr 17, 2004·The American Journal of Surgical Pathology·Anais MalpicaElvio G Silva
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Natalie ReimersKlaus Pantel
Jan 21, 2006·International Journal of Cancer. Journal International Du Cancer·Cornelis F M SierArko Gorter
Apr 25, 2006·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jong-Shiaw JinChien-Yu Bai
Oct 27, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·S SillanpääV-M Kosma
Nov 4, 2009·International Journal of Oncology·Danilo MillimaggiVincenza Dolo
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ReedUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Dec 12, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hong Yang, Biliang Chen
Aug 9, 2013·Journal of Neuro-oncology·Min YangLiang Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.